Parkinsonism in Gaucher's disease type 1: Ten new cases and a review of the literature
✍ Scribed by Ichraf Kraoua; Jérôme Stirnemann; Maria João Ribeiro; Tiphaine Rouaud; Marc Verin; Agnès Annic; Christian Rose; Luc Defebvre; Liliane Réménieras; Michaël Schüpbach; Nadia Belmatoug; Marie Vidailhet; Frédéric Sedel
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 816 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Parkinsonism has been described in patients with Gaucher's disease (GD). We reviewed the 10 cases of patients with both parkinsonism and GD recorded in the French national GD registry, as well as 49 previously published cases. Relative to the general population, parkinsonism in GD patients (1) was more frequent, (2) occurred at an earlier age, (3) responded less well to levodopa, and (4) was more frequently associated with signs of cortical dysfunction. Enzyme replacement therapy (ERT) and substrate reduction therapy (SRT) were ineffective on GD‐associated parkinsonism, suggesting that parkinsonism itself is not an indication for ERT or SRT in this setting. © 2009 Movement Disorder Society
📜 SIMILAR VOLUMES
Pregnancy is rare in Parkinson's disease (PD). In the literature on studies of antiparkinsonian drugs in animals during pregnancy, there are reports on malformations of the skeletal and circulatory system. However, the majority of studies in animals have not shown any teratogenicity. Amantadine has
Anhedonia, defined as lowered ability to experience physical or social pleasure, is a key symptom of several psychiatric illnesses. In this systematic review, we aimed to evaluate the role of anhedonia in Parkinson's Disease and its relationships with other clinical characteristics, dopamine dysfunc